Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/18/2003US20030175243 Blocking receptor binding; gene therapy; gastrin releasing peptide
09/18/2003US20030175231 Contacting epidermal melanocytes with a peptide having amino acid sequence lysine-glycine- alanine to inhibit cell loss, which binds to p75 nerve growth factor receptor expressed on the surface of the melanocytes
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003US20030173284 Separation device
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2529998A1 Feedstock delivery system and fuel processing systems containing the same
09/18/2003CA2518248A1 Proteolysis-resistant active vegf
09/18/2003CA2485142A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
09/18/2003CA2481312A1 Tagging and recovery of elements associated with target molecules
09/18/2003CA2479006A1 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes
09/18/2003CA2478904A1 Modified gene-silencing rna and uses thereof
09/18/2003CA2478640A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
09/18/2003CA2478631A1 Method of inducing an enhanced immune response against hiv
09/18/2003CA2478604A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478593A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478592A1 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003CA2478494A1 Targeted manipulation of genes in plants
09/18/2003CA2478479A1 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478371A1 Compositions and methods for generating an immune response
09/18/2003CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003CA2478245A1 Treatment and prevention of inflammatory disorders
09/18/2003CA2478177A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003CA2478173A1 Novel method of highly sensitive nucleic acid analysis
09/18/2003CA2478169A1 Human antibodies specific to kdr and uses thereof
09/18/2003CA2478126A1 Novel method for the production of hybrid maize seeds
09/18/2003CA2478125A1 Avian cell lines for the production of useful substances
09/18/2003CA2478120A1 Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto
09/18/2003CA2478116A1 Neoplasm specific antibodies and uses thereof
09/18/2003CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/18/2003CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003CA2477980A1 Crystalline structure of human mapkap kinase-2
09/18/2003CA2477975A1 Novel vip3 toxins and methods of use
09/18/2003CA2477780A1 Methods of enhancing immune induction involving mda-7
09/18/2003CA2477577A1 Interferon beta-like molecules for treatment of stroke
09/18/2003CA2477273A1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
09/18/2003CA2476938A1 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
09/18/2003CA2476842A1 Enzymatic ligation-based identification of nucleotide sequences
09/18/2003CA2475738A1 Activated protein c formulations
09/18/2003CA2475735A1 Immunotherapeutics for biodefense
09/18/2003CA2472119A1 Screening method for orthopoxvirus antivirals
09/18/2003CA2449341A1 Novel proteins and nucleic acids encoding same
09/17/2003EP1344837A1 Detection of human immunodeficiency virus type 1
09/17/2003EP1344836A2 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion
09/17/2003EP1344835A2 Real-time nucleic acid detection processes and compositions
09/17/2003EP1344829A1 Paramyxovirus vector encoding angiogenesis gene and use thereof
09/17/2003EP1344827A2 Antifreeze proteins from basidiomycetes
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344825A1 Fohy030 test kits
09/17/2003EP1344824A1 Mutated gene coding for a LAT protein and the biological applications thereof
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344822A1 Method of concentrating gene
09/17/2003EP1344821A1 Novel aggrecanase
09/17/2003EP1344820A1 Zygomycetes-origin endoglucanase lacking cellulose-binding domain
09/17/2003EP1344536A1 Method of regulating the activity of expression product of gene transferred into living body
09/17/2003EP1344181A2 Method and device for selectively targeting cells within a three -dimensional specimen
09/17/2003EP1344065A2 Differential phage capture proteomics
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1344063A1 A screening assay for antagonists of human leukocyte receptors
09/17/2003EP1344062A1 Support for determining an analyte comprising a selective spectral filter
09/17/2003EP1344060A2 Process for determining target function and identifying drug leads
09/17/2003EP1343917A2 Methods for isolation of dna from stool samples
09/17/2003EP1343916A2 Nucleic acid amplification methods
09/17/2003EP1343913A2 Antisense modulation of src-2 expression
09/17/2003EP1343912A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/17/2003EP1343911A2 Microarray method of genotyping multiple samples at multiple loci
09/17/2003EP1343909A2 Methods for large scale protein production in prokaryotes
09/17/2003EP1343906A2 Nucleic acid integration in eukaryotes
09/17/2003EP1343905A1 Adenoviral replicons
09/17/2003EP1343904A2 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof
09/17/2003EP1343903A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
09/17/2003EP1343902A2 Recombinant porcine liver esterases, their use and a method for the production thereof
09/17/2003EP1343901A2 Novel human kinase interacting protein and polynucleotides encoding the same
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343898A1 Novel thermostable galactose isomerase and tagatose production thereby
09/17/2003EP1343897A2 Purified active hcv ns2/3 protease
09/17/2003EP1343896A1 Small acid-soluble spore protein and uses thereof
09/17/2003EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments
09/17/2003EP1343894A1 Aopb gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
09/17/2003EP1343893A1 Production of stilbenes in transgenic plants and the method of producing thereof
09/17/2003EP1343892A2 Compositions and methods for diagnosing or treating psoriasis
09/17/2003EP1343891A2 Colon cancer marker
09/17/2003EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/17/2003EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343885A2 Molecules for disease detection and treatment
09/17/2003EP1343884A2 Jfy1 protein induces rapid apoptosis
09/17/2003EP1343883A2 Aspergillus fumigatus cofilin
09/17/2003EP1343882A2 Compositions, methods and kits for identifying protein-protein interaction disrupting agents
09/17/2003EP1343881A2 Method for generating competent or transformed cells
09/17/2003EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
09/17/2003EP1343879A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
09/17/2003EP1343877A2 Stable composition comprising a nuclease and a phosphatase
09/17/2003EP1343875A2 Sugar beet genes involved in stress tolerance
09/17/2003EP1343874A2 3-hydroxypropionic acid and other organic compounds
1 ... 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 ... 4023